Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valbenazine rollover study for Tardive Dyskinesia
NCT02736955Phase 3Completed
- Sponsor
- Neurocrine Biosciences
- Start
- Jun 2016
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands, Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valbenazine in tardive dyskinesia (TD), sponsored by Neurocrine Biosciences. Started Jun 2016; status: completed.
02
Drugs
valbenazine
03
Conditions
tardive dyskinesia (TD)
Beyond the preview
Go deeper on NCT02736955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02736955.